首页> 外文期刊>Archivio Italiano di Urologia e Andrologia >Tadalafil versus alpha blockers (alfuzosin, doxazosin, tamsulosin and silodosin) as medical expulsive therapy for < 10 mm distal and proximal ureteral stones
【24h】

Tadalafil versus alpha blockers (alfuzosin, doxazosin, tamsulosin and silodosin) as medical expulsive therapy for < 10 mm distal and proximal ureteral stones

机译:他达拉非与α受体阻滞剂(阿夫唑嗪,多沙唑嗪,坦索罗辛和西洛多辛)作为药物排斥疗法用于<10 mm输尿管远端和近端输尿管结石

获取原文
           

摘要

Objectives: To evaluate the effect of tadalafil compared with four alpha blockers (alfuzosin, doxazosin, tamsulosin and silodosin) as medical expulsive treatment for ureteral stones in male adults. Materials and methods: Male adults who were admitted to urology clinic with flank pain and diagnosed with non complicated < 10 mm ureteral stone on non-contrast computed tomography (NCCT) between June 2014-September 2015 were retrospectively evaluated. A total of 273 patients with ureteral stone were divided into five groups. Alfuzosin 10 mg/daily, doxazosin 8 mg/daily, tamsulosin 0.4 mg/daily, silodosin 8 mg/daily and tadalafil 5 mg/daily for 6 weeks were prescribed respectively. Stone localization, diameter, volume and Hounsfield units were noted as NCCT findings. The patients were divided into the two groups based on their stone localization as distal and mid-proximal stones. These two groups were evaluated separately. Expulsion rate were noted at the end of 6 weeks. NCCT and treatment findings were compared between five drug groups in distal and mid-proximal stones separately. Results: Age was higher in tadalafil group in distal stones (p = 0.032). Expulsion rate was found 78.1% for alfuzosin, 75.7% for doxazosin, 76.5% for tamsulosin, 88.6% for silodosin and 90% for tadalafil in distal (p = 0.44) and 21.7%, 30%, 30%, 30% and 54.5% in mid-proximal stones (p = 0.034) respectively. Conclusions: Expulsion rate was higher in silodosin and tadalafil for distal ureteral stones but the difference didn’t meet statistical significance. However the expulsion rate was significantly higher in tadalafil than in the other groups for mid-proximal ureteral stones. The result of this study showed that tadalafil may increases ureteric stone expulsion.
机译:目的:评价他达拉非与四种α受体阻滞剂(阿夫唑嗪,多沙唑嗪,坦索罗辛和西洛多辛)相比,在男性成年人中的医学排斥性治疗效果。材料和方法:回顾性评估2014年6月至2015年9月间在泌尿外科门诊就诊并患有侧面疼痛且经非对比计算机断层扫描(NCCT)诊断为非复杂性<10 mm输尿管结石的男性成年人。总共273例输尿管结石患者分为5组。分别规定阿福唑嗪10毫克/天,多沙唑嗪8毫克/天,坦索罗辛0.4毫克/天,西洛多辛8毫克/天和他达拉非5毫克/天,为期6周。结石定位,直径,体积和Hounsfield单位被记录为NCCT结果。根据患者的结石定位将其分为远端结石和近端结石两类。分别对这两组进行了评估。在6周结束时记录驱逐率。分别比较了远端结石和近端结石的五个药物组之间的NCCT和治疗结果。结果:他达拉非组远端结石的年龄较高(p = 0.032)。远处阿夫唑嗪,多沙唑嗪的驱除率为78.1%,坦沙罗辛的驱除率为76.5%,西洛多辛的驱除率为88.6%,他达拉非的驱除率为(p = 0.44)和21.7%,30%,30%,30%和54.5%在近端结石中(p = 0.034)。结论:西洛多辛和他达拉非对输尿管远端结石的排出率较高,但差异无统计学意义。然而,他达拉非的排泄率显着高于其他组,对于中近端输尿管结石。这项研究的结果表明他达拉非可能增加输尿管结石的排出。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号